| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Fluorescentia is developing an evidence-based platform for therapeutic drug monitoring and precision dosing that leverages breakthrough fluorescent sensor technology developed at the University of Sydney. Using the power of data collected by Fluorescentia's core technology, we are on a mission to improve outcomes for patients undergoing chemotherapy. |
| Category: | Health & biotech |
| URL: | https://fluorescentia.com/ |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2023 |
| Address: | Melbourne, AU |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/fluorescentia |
| Founders: |
No items found
|
| Awards won: | |
